Atra stock forecast.

Mullen Automotive Stock Forecast. Stock Price Forecast. There is currently no analyst price target forecast available for MULN stock. Analyst Consensus: n/a. Target Low Average Median High; Price: n/a: n/a: n/a: n/a: Change: n/a: n/a: n/a: n/a: Analyst Ratings. There are currently no analyst ratings available for MULN. Recommendation …Atara Biotherapeutics Stock Forecast, "ATRA" Share Price Prediction Charts Is "Atara Biotherapeutics Inc" a Good Investment? Current price today: 0.650 USD (+2.331%) …Industry. Packaged Software. No executives to display. Corporate headquarters. Ventura, California. Find real-time TTD - Trade Desk Inc stock quotes, company profile, news and forecasts from CNN ...3 analysts have issued twelve-month target prices for SoundHound AI's stock. Their SOUN share price targets range from $3.60 to $5.00. On average, they expect the company's stock price to reach $4.53 in the next twelve months. This suggests a possible upside of 96.7% from the stock's current price.ASTS Earnings Forecast. Next quarter’s earnings estimate for ASTS is -$0.21 with a range of -$0.21 to -$0.21. The previous quarter’s EPS was -$0.24. ASTS beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 61.91% of the time in the same period.

All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ...Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...

KPRX Stock 12 Months Forecast. $2.75. (347.15% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Kiora Pharmaceuticals in the last 3 months. The average price target is $2.75 with a high forecast of $3.50 and a low forecast of $2.00. The average price target represents a 347.15% change from the last price of $0.62.

Find the latest Atara Biotherapeutics, Inc. ATRA analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. …Atara Biotherapeutics Inc. (ATRA) Company Description. Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188 ...7 equities research analysts have issued 12-month price targets for Luminar Technologies' stock. Their LAZR share price targets range from $3.00 to $20.00. On average, they expect the company's stock price to reach $11.71 in the next twelve months. This suggests a possible upside of 376.2% from the stock's current price.NTRA Stock 12 Months Forecast. $70.40. (31.54% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Natera in the last 3 months. The average price target is $70.40 with a high forecast of $87.00 and a low forecast of $48.00. The average price target represents a 31.54% change from the last price of $53.52.

Nov 22, 2023 · According to analyst projections, ATRA’s forecast low is $0.50 with $28.00 as the target high. To hit the forecast high, the stock’s price needs a -5500.0% plunge from its current level, while the stock would need to tank 0.0% for it to hit the projected low. Atara Biotherapeutics Inc (ATRA) estimates and forecasts

What's Happening With Atara Biotherapeutics Inc Stock Today? Atara Biotherapeutics Inc (ATRA) stock is trading at $0.65 as of 1:00 PM on Friday, Nov 24, a gain of $0.08, or 13.93% from the previous closing price of $0.57. The stock has traded between $0.55 and $0.72 so far today. Volume today is 7,132,201 compared to average volume of 6,444,546.

Find real-time MO - Altria Group Inc stock quotes, company profile, news and forecasts from CNN Business.You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.3 Wall Street analysts have issued 1-year price objectives for Aurora Innovation's stock. Their AUR share price targets range from $1.75 to $7.00. On average, they anticipate the company's share price to reach $3.94 in the next twelve months. This suggests a possible upside of 79.8% from the stock's current price.11 analysts have issued 12-month price objectives for Air Canada's shares. Their AC share price targets range from C$17.00 to C$42.00. On average, they expect the company's share price to reach C$29.63 in the next twelve months. This suggests a possible upside of 68.2% from the stock's current price.6.1%. 10% most volatile stocks in US Market. 15.2%. 10% least volatile stocks in US Market. 2.9%. Stable Share Price: ATRA is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 29% a week. Volatility Over Time: ATRA's weekly volatility has increased from 18% to 29% over the past year.Rite Aid Co. (NYSE:RAD) released its quarterly earnings results on Thursday, April, 20th. The company reported ($1.24) earnings per share for the quarter, missing analysts' consensus estimates of ($0.77) by $0.47. The company earned $6.09 billion during the quarter, compared to analyst estimates of $5.70 billion.

Nov 24, 2023 · The Atara Biotherapeutics stock price gained 13.93% on the last trading day (Friday, 24th Nov 2023), rising from $0.572 to $0.652. During the last trading day the stock fluctuated 29.65% from a day low at $0.552 to a day high of $0.716. The price has risen in 8 of the last 10 days and is up by 171.54% over the past 2 weeks. NTRA Stock 12 Months Forecast. $70.40. (31.54% Upside) Based on 11 Wall Street analysts offering 12 month price targets for Natera in the last 3 months. The average price target is $70.40 with a high forecast of $87.00 and a low forecast of $48.00. The average price target represents a 31.54% change from the last price of $53.52.Oct 24, 2023 · Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2021 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts. 1 equities research analysts have issued twelve-month price objectives for Astra Space's stock. Their ASTR share price targets range from $15.00 to $15.00. On average, they anticipate the company's share price to reach $15.00 in the next year. This suggests a possible upside of 971.4% from the stock's current price.According to the issued ratings of 4 analysts in the last year, the consensus rating for Atara Biotherapeutics stock is Hold based on the current 3 hold ratings and 1 buy rating for ATRA. The average twelve-month price prediction for Atara Biotherapeutics is $28.00 with a high price target of $31.00 and a low price target of $25.00.7 Wall Street research analysts have issued 12 month price objectives for Energy Transfer's shares. Their ET share price targets range from $14.00 to $18.00. On average, they predict the company's share price to reach $16.50 in the next year. This suggests a possible upside of 20.6% from the stock's current price.Stock Price Forecast. The 26 analysts offering 12-month price forecasts for Medtronic PLC have a median target of 89.50, with a high estimate of 104.00 and a low estimate of 68.00. The median ...

Oct 27, 2023 · Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2022 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts.

Stock Price Forecast. According to 33 stock analysts, the average 12-month stock price forecast for Apple stock is $197.09, which predicts an increase of 3.05%. The lowest target is $120 and the highest is $240. On average, analysts rate Apple stock as …Find the latest Workhorse Group Inc. (WKHS) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Atara Biotherapeutics last issued its quarterly earnings results on November 1st, 2023. The biotechnology company reported ($0.66) earnings per share for the quarter, missing analysts' consensus estimates of ($0.63) by $0.03. The business earned $2.14 million during the quarter, compared to analysts' expectations of $2.20 million.Their ATRA share price targets range from $25.00 to $31.00. On average, they expect the company's stock price to reach $28.00 in the next year. This suggests a possible upside of 4,490.2% from the stock's current price. View analysts price targets for ATRA or view top-rated stocks among Wall Street analysts.Earnings Date. Feb 06, 2024 - Feb 12, 2024. Forward Dividend & Yield. N/A (N/A) Ex-Dividend Date. N/A. 1y Target Est. 3.94. Fair Value is the appropriate price for the shares of a company, based ...ATRA Atara Biotherapeutics (ATRA) Stock Forecast for 2023 – 2026. Sell or Buy? Updated: November 24, 2023 (12:38) Sector: Healthcare The share price of …

hace 7 días ... Atara Biotherapeutics Inc [NASDAQ: ATRA] stock went on an upward path that rose over 18.34% on Friday, amounting to a one-week price ...

Find real-time ALDX - Aldeyra Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.

Atara Biotherapeutics Stock Forecast 02 Nov. Presumably, on 11/02/2023, the price of shares will be in the range of $1.24 - $1.28. A $0.04 range width can provide 3.46% volatility. The weighted average price of this range is at $1.26, which is $0.01 lower than the previous day's weighted average price.Great weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.2.46%. $74.52M. Immunogen Inc. 6.11%. $4.3B. ATRA | Complete Atara Biotherapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Find real-time ALDX - Aldeyra Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. CYBN Stock 12 Months Forecast. $5.50. (1067.48% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cybin in the last 3 months. The average price target is $5.50 with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 1067.48% change from the last price of $0.47.See Atara Biotherapeutics, Inc. (ATRA) history of stock splits. Includes date and ratio.With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.Oct 13, 2023 · Atara Biotherapeutics stock price predictions for 2023, 2024, 2025, 2026, 2027 using artificial intelligence. How much will Atara Biotherapeutics cost in 2021-2025? ATRA Stock 12 Months Forecast. $5.05. (890.20% Upside) Based on 8 Wall Street analysts offering 12 month price targets for Atara Biotherapeutics in the last 3 months. The average price target is $5.05 with a high forecast of $13.00 and a low forecast of $1.00. The average price target represents a 890.20% change from the last price of $0.51.

11 analysts have issued 12-month price objectives for Air Canada's shares. Their AC share price targets range from C$17.00 to C$42.00. On average, they expect the company's share price to reach C$29.63 in the next twelve months. This suggests a possible upside of 68.2% from the stock's current price.Nov 16, 2023 · With Atara Biotherapeutics stock trading at $0.38 per share, the total value of Atara Biotherapeutics stock (market capitalization) is $38.73M. Atara Biotherapeutics stock was originally listed at a price of $10.65 in Oct 16, 2014. If you had invested in Atara Biotherapeutics stock at $10.65, your return over the last 9 years would have been ... ... stock price by the number of shares outstanding. Atara Biotherapeutics market cap as of November 03, 2023 is $0.13B. Compare ATRA With Other Stocks. Sector ...Instagram:https://instagram. german economicsphere las vegas capacitymicrocap stocksflywheel teikametrics Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...Predicting the weather has long been one of life’s great mysteries — at least for regular folks. Over the years, you’ve probably encountered a few older adults — maybe even your own grandparents — who made some weather predictions based on ... best option picking serviceportfolio management classes The percentage change in ATRA’s stock price is not provided. Looking ahead, ATRA’s next reporting date is scheduled for August 9, 2023. Analysts forecast an EPS (earnings per share) of -$0.66 for the current quarter. In the previous year, ATRA reported annual revenue of $63.6 million but incurred a net loss of -$228.3 million. 1964 nickels value The consensus price target of analysts on Wall Street is $10.89, which implies an increase of 97.34% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $1.00 and $28.00 respectively. As a result, ATRA is trading at a discount of -9555.17% off the target high and -244.83% off the low.$0.65. DRRX 5.13%. Outlook Therapeutics Inc. $0.47. OTLK 1.50%. Gamida Cell Ltd. $0.33. GMDA 6.45%. Atara Biotherapeutics Inc. $0.65. ATRA 1.85%. Aclaris ...Rite Aid Co. (NYSE:RAD) released its quarterly earnings results on Thursday, April, 20th. The company reported ($1.24) earnings per share for the quarter, missing analysts' consensus estimates of ($0.77) by $0.47. The company earned $6.09 billion during the quarter, compared to analyst estimates of $5.70 billion.